HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pro-opiomelanocortin gene transfer to the nucleus of the solitary track but not arcuate nucleus ameliorates chronic diet-induced obesity.

Abstract
Short-term pharmacological melanocortin activation deters diet-induced obesity (DIO) effectively in rodents. However, whether central pro-opiomelanocortin (POMC) gene transfer targeted to the hypothalamus or hindbrain nucleus of the solitary track (NTS) can combat chronic dietary obesity has not been investigated. Four-weeks-old Sprague-Dawley rats were fed a high fat diet for 5 months, and then injected with either the POMC or control vector into the hypothalamus or NTS, and body weight and food intake recorded for 68 days. Insulin sensitivity, glucose metabolism and adrenal indicators of central sympathetic activation were measured, and voluntary wheel running (WR) assessed. Whereas the NTS POMC-treatment decreased cumulative food consumption and caused a sustained weight reduction over 68 days, the hypothalamic POMC-treatment did not alter cumulative food intake and produced weight loss only in the first 25 days. At death, only the NTS-POMC rats had a significant decrease in fat mass. They also displayed enhanced glucose tolerance, lowered fasting insulin and increased QUICK value, and elevated adrenal indicators of central sympathetic activation. Moreover, the NTS-POMC animals exhibited a near 20% increase in distance ran relative to the respective controls, but the ARC-POMC rats did not. In conclusion, POMC gene transfer to the NTS caused modest anorexia, persistent weight loss, improved insulin sensitivity, and increased propensity for WR in DIO rats. These metabolic improvements may involve stimulation of energy expenditure via centrally regulated sympathetic outflow. The similar POMC treatment in the hypothalamus had minimal long-term physiological or metabolic impact. Thus, melanocortin activation in the brainstem NTS region effectively ameliorates chronic dietary obesity whilst that in the hypothalamus fails to do so.
AuthorsY Zhang, E Rodrigues, Y X Gao, M King, K Y Cheng, B Erdös, N Tümer, C Carter, P J Scarpace
JournalNeuroscience (Neuroscience) Vol. 169 Issue 4 Pg. 1662-71 (Sep 15 2010) ISSN: 1873-7544 [Electronic] United States
PMID20538045 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Copyright(c) 2010 IBRO. Published by Elsevier Ltd. All rights reserved.
Chemical References
  • Pro-Opiomelanocortin
Topics
  • Adipose Tissue (anatomy & histology, physiology)
  • Animals
  • Arcuate Nucleus of Hypothalamus (metabolism, surgery)
  • Chronic Disease
  • Disease Models, Animal
  • Genetic Therapy (methods)
  • Male
  • Obesity (etiology, genetics, therapy)
  • Pro-Opiomelanocortin (genetics)
  • Rats
  • Rats, Sprague-Dawley
  • Solitary Nucleus (metabolism, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: